Issue 27: Pharma Digest

The Digest is for you, the valued members of our pharma community. Receive the latest market movements, breaking pharma news, business-critical whitepapers and content, and updates on our exclusive executive summits. Don’t forget to subscribe using the button above.

Let's get started.

How AI and new sources of high-quality data are redefining pharma’s approach to RWE

By synthesising RWE and AI, the industry can capitalise on the proliferation of data and unlock insights to drive the development and commercialisation of breakthrough medicines.

Access insights from JNJ, Bayer, Moderna, Novartis and more – download the whitepaper here.

Strategies for marketing success

Physicians and patients are being exposed to more content than ever, both from pharma and other sources, and it is becoming harder and harder to stand out.

The good news? In the omnichannel era, pharma companies have more options for getting messages to their targets, and the successes of companies as varied as IKEA and TikTok offer insights into how to cut through the noise and deliver effective campaigns.

In this exclusive report, we summarize key learnings and guidance from marketing and customer experts. Download your copy of the report now.

"When you think about the voice of the patient in changing policy, to advocate for better health - there is no more powerful voice." - Eric Racine, PharmD, MBA, Sanofi. In this conversation Eric talks with Chris Bombardier and Tirsa Carcamo about their inspiring journeys within the bleeding disorder community and what they feel revolutionary change making looks like. Click here to watch the full session.

Learn about the importance of early collaboration to drive a patient first culture, with Moreno Perugini, President of Active & Medical Nutrition, U.S. & President of Global Pharmaceutical Therapies, Nestlé Health Science.?Listen to the episode here?or?find us on Spotify.?

Top 5 pharma news to watch

1. Pfizer fleshes out oncology strategy, targeting 8 blockbuster cancer drugs by 2030 (Fierce Pharma, February 29)
2. Exclusive: Musk's Neuralink brain implant company cited by FDA over animal lab issues (Reuters.com, March 1)
3. Ginkgo adds gene editing tools in buyout of Feng Zhang-founded startup (BioPharma Dive, February 28)
4. ‘Top-down’ treatment strategy dramatically improves outcomes for Crohn’s patients (PharmaTimes, February 29)
5. AbbVie And OSE Immunotherapeutics Announce Partnership To Develop A Novel Monoclonal Antibody For The Treatment Of Chronic Inflammation (Pharma Journalist, March 1)

Event Spotlight

North America’s largest cross-functional pharma gathering.

All pass types re-opened THIS WEEK ONLY! Secure your place with FLASH350 for $350 off any pass - Valid until March 1! Register now.

That rounds off Issue 27 of the Pharma Digest.

We'll be back in two weeks with more important news, market updates, pharma content, and updates on our events. Don’t forget to subscribe to receive a notification for our next bi-weekly digest.

As always, the Pharma team are on hand to answer your questions. You can connect with us on LinkedIn.

EU Team

Daniel Baker

Daisy Beale

Karla Sharp

Patrycja Cybinska

USA Team

Kana Hutton

Suzy Wang

Charlotte Bastiaanse

Marko Mitrovic

See you next time!